Pfizer Ltd. (PFIZER) Share Price Rises 4.01% Today After Clearing Large Cap Threshold

Pfizer Ltd. traded at Rs 5,096.10, up 4.01% today, with a market capitalisation of Rs 22,302.48 crore, clearing the qualifying bar for a Large Cap price rise event.

Pfizer Ltd. Share Price is in focus on 12 August 2026 after the stock rose to Rs 5,096.10, up Rs 196.65 or 4.01% for the day, taking its market capitalisation to Rs 22,302.48 crore. In today’s Stock Market Today setup, that move was large enough to qualify under the Large Cap category threshold, making Pfizer Ltd. one of the notable Stocks in News and a top gainer to track.

The verified data confirms the price rise, the trading range and the volume footprint, but it does not establish a company-specific catalyst for why the stock is rising today. Even so, the move matters because it was not marginal noise: the stock opened at Rs 4,919.95, stayed above its day low of Rs 4,917.65 and climbed to an intraday high of Rs 5,125. That places Pfizer Ltd. Share Price Today firmly in the day’s active market movers list.

For readers searching Pfizer Ltd. Stock News, Pfizer Ltd. Share Price Today or Why Is Pfizer Ltd. Rising Today, the key facts are straightforward. The stock is higher by 4.01%, the move cleared its market-cap-based qualifying bar, total traded volume stood at 57,621 shares across exchanges, and turnover was Rs 2.56 crore. Univest notes that the data confirms strong same-day price action, while the next layer for investors is to assess whether this move is supported by broader sector and peer positioning.

Pfizer Ltd. (PFIZER) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 5,096.1
Previous Close	Rs 4,899.45
Today's Change	+Rs 196.65 (+4.01%)
Day Open	Rs 4,919.95
Day High	Rs 5,125
Day Low	Rs 4,917.65
Current Volume (BSE)	5,016
BSE Traded Volume	5,016
NSE Traded Volume	52,605
Combined NSE + BSE Volume	57,621
Turnover	Rs 2.56 crore
Market Capitalisation	Rs 22,302.48 crore
Market Cap Category	Large Cap

Pfizer Ltd. (PFIZER) traded at Rs 5,096.1. versus the previous close of Rs 4,899.45, a rise of 4.01%. The stock opened at Rs 4,919.95, reached Rs 5,125, touched Rs 4,917.65. Reported volume was 5,016.

Pfizer Ltd. (PFIZER) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 22,302.48 crore

Pfizer Ltd. Share Price is attracting attention primarily because of today’s move, but the supplied fundamental context begins with company size. The stock’s market capitalisation stands at Rs 22,302.48 crore, which is materially above the supplied Healthcare sector benchmark average market cap of Rs 461.64 crore and the benchmark median of Rs 142.81 crore. That size differential matters because market capitalisation indicates company size, not quality, and it shows Pfizer Ltd. sits far above the typical company included in the same-sector benchmark set.

In practical terms, that large market value places Pfizer Ltd. in a very different scale bracket from many healthcare names in the comparison universe. The benchmark market-cap range spans from Rs 3.88 crore to Rs 2,949.87 crore across 196 companies, while Pfizer Ltd. at Rs 22,302.48 crore stands well beyond even that supplied maximum. For investors following Pfizer Ltd. Share Price Rise, this means the stock’s movement is happening in a company that is much larger than the benchmark sample used for sector context.

Because the verified dataset for this article does not include Pfizer Ltd.’s own P/E ratio, P/B ratio, EV/EBITDA, ROE, ROCE, EPS, book value, dividend yield, debt metrics, margins or cash-flow figures, today’s fundamental analysis is necessarily centred on scale, market presence within the listed universe and relative position versus the sector snapshot and peers available in the data. That still provides useful context: a Rs 22,302.48 crore Healthcare company posting a 4.01% same-day gain is more noteworthy than a similar percentage move in a much smaller stock.

For readers looking up Pfizer Ltd. Fundamental Analysis, the disciplined takeaway from Univest is that the event is validated by price and size data, while the deeper judgment on value and financial quality must be anchored to the peer and benchmark numbers that are actually supplied. That makes shareholding context unnecessary here and shifts the analysis directly toward sector and peer comparison.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	25.58x
Benchmark Average P/E	81.68x
Benchmark P/E Range	3.31x to 3,374.81x
Benchmark Median P/B	1.9x
Benchmark Median ROE	11.07%
Benchmark Median ROCE	13.35%
Company Market Capitalisation	Rs 22,302.48 crore
Benchmark Median Market Cap	Rs 142.81 crore

Pfizer Ltd. (PFIZER) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Pfizer Ltd. Share Price is moving higher within the broader Healthcare sector, and the supplied sector benchmark gives a useful frame for today’s move. Across the same-sector universe of 196 companies, the benchmark median P/E is 25.58 and the average P/E is 81.68, with the full range running from 3.31 to 3,374.81. That wide spread shows valuation dispersion is very high across healthcare names, so investors should treat sector averages carefully rather than as a simple one-line conclusion.

The same-sector benchmark also shows a median P/B ratio of 1.9 and an average P/B ratio of 2.6 across 195 companies, with values ranging from -16.74 to 16.32. On profitability, the benchmark median ROE stands at 11.07% and the average at 15.45%, while median ROCE is 13.35% and average ROCE is 17.8%. These figures matter because they establish the profitability and valuation backdrop against which healthcare stocks are being compared in the current Market News cycle.

Market capitalisation statistics underline how unusually large Pfizer Ltd. is relative to this benchmark scope. The sector median market cap is Rs 142.81 crore, the average is Rs 461.64 crore, the minimum is Rs 3.88 crore and the maximum is Rs 2,949.87 crore. Pfizer Ltd.’s Rs 22,302.48 crore market capitalisation sits far above that range, which means its Pfizer Ltd. Stock Performance should be assessed with care when comparing it against smaller healthcare counters.

For investors reading Pfizer Ltd. Share Price News, the sector picture is therefore mixed but informative. Healthcare is not a homogeneous basket; it includes pharmaceuticals and drugs players as well as hospital and healthcare services names in the supplied benchmark companies. Univest reads today’s move as significant mainly because a large-cap healthcare stock delivered a qualifying gain in a sector where size, valuations and profitability vary sharply across the listed universe.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,949.87	31.07	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,775.9	71.31	11.28	18.65	22.17
Hikal Ltd.	HIKAL	2,761.32	0	2.26	15.22	16.15
Sai Parenteral's Ltd.	SAIPARENT	2,594.65	179.52	3.32	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,561.88	33.61	6.93	-2.6	16.92

Pfizer Ltd. (PFIZER) has a market capitalisation of Rs 22,302.48 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Pfizer Ltd. Share Price also stands out when placed beside the supplied peers because the market-cap gap is striking. The peer list ranges from Dishman Carbogen Amcis Ltd. at Rs 2,949.87 crore to Ind-Swift Laboratories Ltd. at Rs 2,061.86 crore, while Pfizer Ltd. is valued at Rs 22,302.48 crore. That means Pfizer Ltd.’s market capitalisation is several times larger than every named peer in the comparison set, making it the clear outlier on size.

Among peers with available P/E data, valuations vary materially. Dishman Carbogen Amcis trades at 31.07, Beta Drugs at 71.31, Sai Parenteral’s at 179.52, Dr Agarwals Eye Hospital at 33.61, NGL Fine-Chem at 44.41, Hester Biosciences at 15.51 and Ind-Swift Laboratories at 43.16. This spread reinforces the sector-level point that healthcare valuations are dispersed, and it also means any interpretation of Pfizer Ltd. Share Price Rise should avoid simplistic peer conclusions unless company-specific valuation data is available.

Profitability across the peer group is equally uneven. ROE ranges from -2.89% at Dishman Carbogen Amcis and -2.6% at Dr Agarwals Eye Hospital to 27.9% at NGL Fine-Chem. ROCE ranges from -0.26% at Dishman Carbogen Amcis to 33.91% at NGL Fine-Chem. Beta Drugs posts 18.65% ROE and 22.17% ROCE, while Hikal shows 15.22% ROE and 16.15% ROCE. Sai Parenteral’s records 13.9% ROE and 12.97% ROCE, and Hester Biosciences reports 16.17% ROE and 14.12% ROCE.

For Pfizer Ltd. Stock Analysis, the most defensible conclusion from the supplied peer set is structural rather than directional: Pfizer Ltd. is much larger than these names, while peer valuation and profitability metrics show a broad range of outcomes within Healthcare. Univest therefore sees the peer data as context for sector diversity rather than proof of relative cheapness or expensiveness in Pfizer Ltd. Share Price Today.

Why Investors Are Watching Pfizer Ltd.

Pfizer Ltd. Share Price is on investor radar because today’s move combined a qualifying gain, a large market capitalisation and measurable exchange activity. In a market where many Stocks Rising Today are smaller counters, a 4.01% gain in a Rs 22,302.48 crore Healthcare company naturally gets more attention from traders, researchers and long-term market watchers.

• Verified price action: the stock rose from Rs 4,899.45 to Rs 5,096.10, gaining Rs 196.65 or 4.01%.
• Threshold relevance: Pfizer Ltd.
• Trading footprint: total volume stood at 57,621 shares, including 5,016 on BSE and 52,605 on NSE, with Rs 2.56 crore turnover.
• Scale factor: market capitalisation of Rs 22,302.48 crore is far above the same-sector benchmark average of Rs 461.64 crore.
• Sector lens: the Healthcare benchmark covers 196 companies with wide valuation and profitability dispersion.

What investors may monitor next is whether Pfizer Ltd. Share Price holds close to the upper end of today’s range after touching Rs 5,125, and whether follow-through trading keeps the stock among active Market Movers. Univest also suggests tracking how this move is interpreted alongside the broader Healthcare peer and benchmark framework rather than in isolation.

About Pfizer Ltd.

Pfizer Ltd. is listed under the symbol PFIZER and is being tracked here within the Healthcare sector. In today’s Pfizer Ltd. Company News and Pfizer Ltd. Share News context, the stock’s listing identity, sector classification and market scale are the key verified reference points available in the dataset. The company’s market capitalisation is Rs 22,302.48 crore, which places it in the Large Cap category for this event framework.

From a market-structure perspective, that size makes Pfizer Ltd. a prominent healthcare listing relative to the benchmark universe supplied for this article. The same-sector comparison set spans 196 companies and includes both Pharmaceuticals & Drugs names and Hospital & Healthcare Services names. That broad benchmark reminds readers that Healthcare on the Indian Stock Market covers multiple business models, valuation bands and profitability profiles.

For anyone searching Pfizer Ltd. Latest News, Pfizer Ltd. Market Cap or Pfizer Ltd. Stock News, the most relevant factual introduction today is that this is a large listed healthcare company whose share price has registered a qualifying same-day gain. On Univest, investors typically combine such event data with ongoing monitoring of Share Price, Stock Price movement, market capitalisation trends and sector positioning to build a fuller Market Update around the stock.

Track Pfizer Ltd. Share Price on Univest

Use Pfizer Ltd. (PFIZER) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Pfizer Ltd. Share Price can be tracked on Univest for live market movement, broader stock analysis and event-based monitoring. Users following Pfizer Ltd. Share Price Today, Pfizer Ltd. Share Price Live or Pfizer Ltd. Share Price Update often look beyond a single session and review price history, 52 Week High and 52 Week Low context, sector comparison and market-cap positioning in one place.

Univest also helps readers organise Pfizer Ltd. Stock News through a structured lens that includes price action, peer comparison, shareholding pattern when available, technical indicators when supplied, and company-level market insights. For active users of NSE News, BSE News and daily Stock Updates, the platform’s value lies in bringing verified numbers into one connected view without turning them into unsupported recommendations.

Frequently Asked Questions

What is Pfizer Ltd. Share Price today?

Ans. Pfizer Ltd. Share Price today was Rs 5,096.10 at the time of this article. The stock was up Rs 196.65 from the previous close of Rs 4,899.45, translating into a 4.01% gain during the session.

Why is Pfizer Ltd. Share Price rising today?

Ans. The supplied data confirms that Pfizer Ltd. Share Price rose 4. It also shows active trading volume and a day high of Rs 5,125, but no company-specific catalyst is established.

How much did Pfizer Ltd. stock gain in today’s trade?

Ans. Pfizer Ltd. stock gained Rs 196.65 in absolute terms and 4.01% in percentage terms today. That lifted the stock from a previous close of Rs 4,899.45 to a current price of Rs 5,096.10.

What was the day range for Pfizer Ltd. Share Price Today?

Ans. Pfizer Ltd. Share Price Today traded between Rs 4,917.65 and Rs 5,125. The stock opened at Rs 4,919.95, which means it held above the previous close early and later moved to the upper end of the session range.

Did Pfizer Ltd. clear the required threshold for its category?

Ans. Yes. Pfizer Ltd. The stock’s 4.01% gain was just enough to clear that exact bar on the day.

What was the trading volume in Pfizer Ltd. today?

Ans. Total traded volume in Pfizer Ltd. stood at 57,621 shares. Of this, 5,016 shares were on BSE and 52,605 shares were on NSE, while reported turnover for the session was Rs 2.56 crore.

What is Pfizer Ltd.’s market capitalisation?

Ans. Pfizer Ltd.’s market capitalisation is Rs 22,302.48 crore. That makes it substantially larger than the Healthcare sector benchmark average of Rs 461.64 crore and even higher than the benchmark maximum of Rs 2,949.87 crore.

How does Pfizer Ltd. compare with the Healthcare sector benchmark?

Ans. Pfizer Ltd. is being tracked within Healthcare, where the same-sector benchmark covers 196 companies. The benchmark median P/E is 25.58 and median ROCE is 13.35%, while Pfizer Ltd. notably stands out on market capitalisation at Rs 22,302.48 crore.

Which peers are included in the Pfizer Ltd. comparison?

Ans. The supplied peer set includes Dishman Carbogen Amcis, Beta Drugs, Hikal, Sai Parenteral’s, Dr Agarwals Eye Hospital, Solara Active Pharma Sciences, Panacea Biotec, NGL Fine-Chem, Hester Biosciences and Ind-Swift Laboratories.

Why are investors watching Pfizer Ltd. Stock News today?

Ans. Investors are watching Pfizer Ltd. Stock News because the stock gained 4.01%, cleared the Large Cap threshold, traded up to Rs 5,125 and did so in a company with a market capitalisation of Rs 22,302.48 crore.